FDA Warning Letter — Glenmark Pharmaceuticals Inc., USA

Case 73604 — FEI 3005658103

The FDA took a Warning Letter action against Glenmark Pharmaceuticals Inc., USA on Mar 16, 2010 (Elmwood Park, NJ). The action was issued by CDER and concerns drugs products. This facility has 3 recent FDA inspections on record.

Action details

Facility
Glenmark Pharmaceuticals Inc., USA
Date
Mar 16, 2010
Fiscal Year
2010
Product Type
Drugs
Center
CDER
Location
Elmwood Park, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.